Hypoglycemia and the sympathoadrenal system: neurogenic symptoms are largely the result of sympathetic neural, rather than adrenomedullary, activation.
about
Glucose counterregulatory responses to hypoglycemia.Challenges in Modelling Hypoglycaemia-Associated Autonomic Failure: A Review of Human and Animal StudiesClinicopathological characteristics and non-adhesive organ culture of insulinomas.Attenuation of counterregulatory responses to recurrent hypoglycemia by active thalamic inhibition: a mechanism for hypoglycemia-associated autonomic failure.Hypoglycemia in type 1 diabetes mellitus.Counterregulatory deficits occur within 24 h of a single hypoglycemic episode in conscious, unrestrained, chronically cannulated mice.Role of the carotid body chemoreceptors in baroreflex control of blood pressure during hypoglycaemia in humans.Adrenergic mediation of hypoglycemia-associated autonomic failureStrategies for optimizing glycemic control and cardiovascular prognosis in patients with type 2 diabetes mellitus.Evolution of concepts of stress.Hypoglycemia, an old tool for new findings in the adrenomedullary hormonal system in patients with rheumatic diseases.Defective counterregulation and hypoglycemia unawareness in diabetes: mechanisms and emerging treatments.EphA5-EphrinA5 interactions within the ventromedial hypothalamus influence counterregulatory hormone release and local glutamine/glutamate balance during hypoglycemia.Glucagon secretion and autonomic signaling during hypoglycemia in late pregnancyEffects of a selective serotonin reuptake inhibitor, fluoxetine, on counterregulatory responses to hypoglycemia in healthy individuals.Philip E. Cryer, MD: Seminal Contributions to the Understanding of Hypoglycemia and Glucose Counterregulation and the Discovery of HAAF (Cryer Syndrome)The barrier of hypoglycemia in diabetes.Attenuated sympathoadrenal responses, but not severe hypoglycemia, during aggressive glycemic therapy of early type 2 diabetes.Cardiac implications of hypoglycaemia in patients with diabetes - a systematic reviewEmergency neurological life support: acute non-traumatic weakness.Hypoglycemia in patients with type 1 diabetes: epidemiology, pathogenesis, and prevention.Severe hypoglycaemia in type 1 diabetes mellitus: underlying drivers and potential strategies for successful prevention.Emergency Neurological Life Support: Acute Non-traumatic Weakness.Interdisciplinary approach to compensation of hypoglycemia in diabetic patients with chronic heart failure.Hypoglycemia activates arousal-related neurons and increases wake time in adult rats.Mechanisms of sympathoadrenal failure and hypoglycemia in diabetes.Occult sporadic insulinoma: localization and surgical strategy.Distribution and neurochemical characterization of neurons in the rat ventrolateral medulla activated by glucoprivation.[Hypoglycemia as a limiting factor in the management of type 1 diabetes].Fish oil attenuates adrenergic overactivity without altering glucose metabolism during an oral glucose load in haemodialysis patients.Antecedent short-term central nervous system administration of estrogen and progesterone alters counterregulatory responses to hypoglycemia in conscious male rats.Emergency Neurological Life Support: Acute Non-traumatic Weakness.Effects of low and high protein:carbohydrate ratios in the diet of pregnant gilts on maternal cortisol concentrations and the adrenocortical and sympathoadrenal reactivity in their offspring.Decreased pituitary response to insulin-induced hypoglycaemia in young lean male patients with essential hypertension.Oxidative stress and autonomic nerve function in early type 1 diabetes.
P2860
Q27686872-B81739FD-E896-4C11-9436-1054C8056B50Q28080116-DBC53BB3-3863-4D50-8B19-4E32BDA64CB3Q30483805-10B2102A-BE88-4305-A789-D2D31AF1C399Q31136480-35852E8D-290A-4E9B-9E45-3727B32224F6Q34072593-72E59C2D-4004-49AC-9E66-EB1ED322A0B6Q34482272-781850E8-F196-43C3-8DEC-A72FD01AF33EQ34488492-2C9845E5-A991-4EB5-AA7C-118817238A23Q34527195-85BBB2D8-4213-4EDF-9F0B-9479AA42936AQ34541875-7C82305D-72C5-4C7D-9AE9-EA2E17496D2BQ34630097-A5CEE37E-8CE9-45C1-A5AD-4CC18A12C740Q36541297-E3B536C1-4BE0-4310-AC1B-D2ED56852201Q36597980-50D86B66-840C-4B39-BD5C-2CC86F65E262Q36720651-95A37034-9EEF-4654-B5A5-2CBE9B1E896DQ36724822-6CDB5203-7098-4F28-8445-3B05C3BFCA09Q36842624-20387B01-9C82-4ACD-AD55-788400749E97Q36926325-03393147-9F86-4C52-9F83-B55302221405Q36975419-BC4CA077-7D14-4626-8AFD-DC9B59F3280DQ37105269-0659B499-3E02-42E3-9B10-3724FB594008Q37361386-83A55E20-D1A7-4D8D-9675-F443C385A2E9Q38042829-DD09FDC8-EC05-453A-87D3-EA768200C13DQ38126386-DA629F09-B0D9-4111-BAA3-95172CA38FEFQ38159475-65E1AEE0-4719-46CA-A843-15B0C554A12CQ38599739-819D5140-1354-453C-89D7-B08D3E89F7C0Q38604382-6C90D8E8-3F31-45FB-97D6-D1DDBCB80003Q40223318-5C15EC7A-40AA-4B65-A274-E383B7A18007Q42506101-949FE7CA-B1B7-4D67-87B9-AE5382DE25A3Q43125107-08778F54-1ABB-412E-8362-E3A173E17A1EQ45062236-B1750B44-98F9-417B-986A-77C4D8AFC5CAQ46625429-F2272972-7C64-4473-BE3C-D33B17F1C39EQ46918936-F1A69967-97B1-4618-8B86-0BCB04E4DC08Q46947701-9AAE327F-82E2-46EF-AAFA-7F16CF99F1AAQ47771167-6AC1ED47-1A2C-4045-A8B8-A5FCAD7B7809Q48130173-FEF7319D-A59E-44A5-9082-38769BCC2144Q48582590-08FCA86B-676A-4CD0-98B1-3AB0F6E6FA69Q51152548-86FEC463-1581-4771-A903-F12D42159C12
P2860
Hypoglycemia and the sympathoadrenal system: neurogenic symptoms are largely the result of sympathetic neural, rather than adrenomedullary, activation.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Hypoglycemia and the sympathoa ...... n adrenomedullary, activation.
@en
Hypoglycemia and the sympathoa ...... n adrenomedullary, activation.
@nl
type
label
Hypoglycemia and the sympathoa ...... n adrenomedullary, activation.
@en
Hypoglycemia and the sympathoa ...... n adrenomedullary, activation.
@nl
prefLabel
Hypoglycemia and the sympathoa ...... n adrenomedullary, activation.
@en
Hypoglycemia and the sympathoa ...... n adrenomedullary, activation.
@nl
P2860
P1476
Hypoglycemia and the sympathoa ...... n adrenomedullary, activation.
@en
P2093
Michael A DeRosa
Philip E Cryer
P2860
P304
P356
10.1152/AJPENDO.00539.2003
P577
2004-02-17T00:00:00Z